Contemporary autochthonous human Chagas disease in the USA

Lynn, Mary K.; Bossak, Brian H.; Sandifer, Paul A.; Watson, Annette; Nolan, Melissa S.

doi:10.1016/j.actatropica.2020.105361

Cited by 65 publications

(55 citation statements)

References 37 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…(12,28,29) According to Lynn, et al, they found that shared risk factors for transmission of Chagas disease in the United States were living in a rural area and/or a history of outdoor activities or work. (15) This leads us to conclude that healthcare providers serving populations in rural areas or underserved migrant population are a good starting point to target Chagas disease education efforts. (12,(29)(30)(31) As of 2017, only six states participate in surveillance and reporting of Chagas disease.…”

Section: Introductionmentioning

confidence: 99%

“…(13,14) However, in the southern United States there have been an increasing number of autochthonous and congenital transmission cases being reported since 2000. (3,(15)(16)(17)(18)(19) It is generally believed that transmission rates in the United States are lower than in Latin America, mainly because of housing conditions and different vector behaviors. (16,20) Nevertheless, there are 29 out of 50 states reporting triatomine insects with 10 of the 11 species found to have the ability to be infected with the parasite.…”

Section: Introductionmentioning

confidence: 99%

“…(16,20) Nevertheless, there are 29 out of 50 states reporting triatomine insects with 10 of the 11 species found to have the ability to be infected with the parasite. (15,21,22) In several studies of triatomines collected in Texas, more than 60% were infected with T. cruzi and of those infected many had human blood in their gut. (22)(23)(24)(25)(26) Many of these studies suggest that locally acquired infections in the United States may occur more frequently than previously thought, however due to a lack of knowledge about Chagas disease in the United States it is often overlooked.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Assessing the Effectiveness of Chagas Disease Education for Healthcare Providers in the United States

Granados

Pacheco²,

Patlán³

et al. 2020

Preprint

View full text Add to dashboard Cite

Background Chagas disease is a zoonotic infection caused by the parasite Trypanasoma cruzi, which affects an estimated 8–11 million people globally. Chagas disease is almost always associated with poverty in rural areas and disproportionately impacts immigrants from Latin America living in the United States. Approximately 20–30% of people who are infected with Chagas disease will develop a chronic form of the infection that can be fatal if left untreated. Chagas disease is vastly underestimated in the United States, often goes undiagnosed and is not well understood by most U.S. healthcare providers. One of the most important ways at reducing barriers to improving diagnostics of Chagas disease in the U.S. is giving healthcare providers the most up-to-date information and access to leading experts. Methods An online webinar was conducted for healthcare providers, veterinarians and public health professionals using Chagas disease expert panelists. Pre and post tests were administered to participants (n = 57) to determine the efficacy in raising awareness and to determine key focus areas for improving knowledge. A Wilcoxon rank-sum was used for non-parametric variables equivalent and for questions that assessed knowledge the McNemar’s Chi-Square test was used. Results There were statistically significant learning increases in multiple categories including transmission (p = < .001), clinical presentation (p = 0.016), diagnostics (p = < .001), and treatment (p = < .001). Conclusion Providing easily accessible learning opportunities using validated testing and evaluations should be further developed for rural healthcare providers in the U.S. as well as healthcare providers serving under represented populations such as immigrants. There is a clear lack of knowledge and awareness surrounding Chagas disease in the United States and just by raising awareness and providing education on the topic, lives will be saved.

show abstract

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Assessing the Effectiveness of Chagas Disease Education for Healthcare Providers in the United States

Granados

Pacheco²,

Patlán³

et al. 2020

Preprint

View full text Add to dashboard Cite

show abstract

“…This population may hold the highest burden of Chagas disease in the United States due to a higher prevalence in their countries of origin [13,14]. However, in the southern United States there have been an increasing number of autochthonous and congenital transmission cases being reported since 2000 [3,[15][16][17][18][19]. It is generally believed that transmission rates in the United States are lower than in Latin America, mainly because of housing conditions and different vector behaviors [16,20].…”

Section: Introductionmentioning

confidence: 99%

Assessing the effectiveness of Chagas disease education for healthcare providers in the United States

et al. 2020

View full text Add to dashboard Cite

Background Chagas disease is a zoonotic infection caused by the parasite Trypanosoma cruzi, which affects an estimated 8–11 million people globally. Chagas disease is almost always associated with poverty in rural areas and disproportionately impacts immigrants from Latin America living in the United States. Approximately 20–30% of people who are infected with Chagas disease will develop a chronic form of the infection that can be fatal if left untreated. Chagas disease is vastly underestimated in the United States, often goes undiagnosed and is not well understood by most U.S. healthcare providers. One of the most important ways at reducing barriers to improving diagnostics of Chagas disease in the U.S. is giving healthcare providers the most up-to-date information and access to leading experts. Methods An online webinar was conducted for healthcare providers, veterinarians and public health professionals using Chagas disease expert panelists. Pre and post tests were administered to participants (n = 57) to determine the efficacy in raising awareness and to determine key focus areas for improving knowledge. A Wilcoxon rank-sum was used for non-parametric variables equivalent and for questions that assessed knowledge the McNemar’s Chi-Square test was used. Results There were statistically significant learning increases in multiple categories including transmission (p = <.001), clinical presentation (p = 0.016), diagnostics (p = <.001), and treatment (p = <.001). Conclusion Providing easily accessible learning opportunities using validated testing and evaluations should be further developed for rural healthcare providers in the U.S. as well as healthcare providers serving under represented populations such as immigrants. There is a clear lack of knowledge and awareness surrounding Chagas disease in the United States and just by raising awareness and providing education on the topic, lives will be saved.

show abstract

“…parasite. (15,21,22) In several studies of triatomines collected in Texas, more than 60% were infected with T. cruzi and of those infected many had human blood in their gut. (22)(23)(24)(25)(26) Many of these studies suggest that locally acquired infections in the United States may occur more frequently than previously thought, however due to a lack of knowledge about Chagas disease in the United States it is often overlooked.…”

mentioning

confidence: 99%

Assessing the Effectiveness of Chagas Disease Education for Healthcare Providers in the United States

Granados

Pacheco²,

Patlán³

et al. 2020

Preprint

View full text Add to dashboard Cite

Background: Chagas disease is a zoonotic infection caused by the parasite Trypanosoma cruzi, which affects an estimated 8-11 million people globally. Chagas disease is almost always associated with poverty in rural areas and disproportionately impacts immigrants from Latin America living in the United States. Approximately 20-30% of people who are infected with Chagas disease will develop a chronic form of the infection that can be fatal if left untreated. Chagas disease is vastly underestimated in the United States, often goes undiagnosed and is not well understood by most U.S. healthcare providers. One of the most important ways at reducing barriers to improving diagnostics of Chagas disease in the U.S. is giving healthcare providers the most up-to-date information and access to leading experts. Methods: An online webinar was conducted for healthcare providers, veterinarians and public health professionals using Chagas disease expert panelists. Pre and post tests were administered to participants (n=57) to determine the efficacy in raising awareness and to determine key focus areas for improving knowledge. A Wilcoxon rank-sum was used for non-parametric variables equivalent and for questions that assessed knowledge the McNemar’s Chi-Square test was used.Results: There were statistically significant learning increases in multiple categories including transmission (p=<.001), clinical presentation (p= 0.016), diagnostics (p=<.001), and treatment (p=<.001). Conclusion: Providing easily accessible learning opportunities using validated testing and evaluations should be further developed for rural healthcare providers in the U.S. as well as healthcare providers serving under represented populations such as immigrants. There is a clear lack of knowledge and awareness surrounding Chagas disease in the United States and just by raising awareness and providing education on the topic, lives will be saved.

show abstract

Contemporary autochthonous human Chagas disease in the USA

Cited by 65 publications

References 37 publications

Assessing the Effectiveness of Chagas Disease Education for Healthcare Providers in the United States

Assessing the Effectiveness of Chagas Disease Education for Healthcare Providers in the United States

Assessing the effectiveness of Chagas disease education for healthcare providers in the United States

Assessing the Effectiveness of Chagas Disease Education for Healthcare Providers in the United States

Contact Info

Product

Resources

About